 |
|
|
|
|
Utah Life Science Industry Directory
Target your advertising by state, region or nationwide for the same low rate
Banner Advertising | Event Advertising
Myriad Genetics, Inc.
| | | | | Phone: | (801) 584-3600 | | Fax: | (801) 584-3640 | | Year Established: | 1991 | | Employees: | 500 | | Ticker: | MYGN | | Exchange: | NASDAQ | | Main Contact: | John Gill, JD, MBA, Senior Director, Business Development | | | | Other Contacts: | Gary A. King, Executive VP, International Operations
Robert G. Harrison, CIO
Bryan Riggsbee, CFO
Ralph L. McDade Ph.D., President, Myriad RBM
Mark C. Capone, President & CEO
| | | | Company Description | | Myriad Genetics is a leading biopharmaceutical company focused on the development of novel healthcare products. Myriad has a full pipeline of preclinical drug candidates in development including two Phase I human clinical trials for cancer drugs, Azixa™ and MPC-2130. The Company markets molecular diagnostic tests to determine the risk of breast cancer, ovarian cancer, colon cancer, endometrial cancer and melanoma skin cancer in individuals with a family history of cancer. | |
|
|
|
|
|
|
|
